価格表

在庫・価格 : 2025年04月26日 12時52分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
NS-304
データシート
10010411 CAYケイマン ケミカル
Cayman Chemical Company
50 mg ¥32,400
(未発注)
追加

在庫・価格 : 2025年04月26日 12時52分 現在

NS-304

  • 商品コード:10010411
  • メーカー:CAY
  • 包装:50mg
  • 価格: ¥32,400
  • 在庫:無(未発注)
参考文献
No. 文献情報 備考 参照
1 Cui Y et al. Protective effect of prostaglandin I(2) analogs on ischemic delayed neuronal damage in gerbils. Biochem. Biophys. Res. Commun. 1999 Nov;265(2):301-4
Cui Y et al
1999/01/01
PubMed
2 Southall MD et al. Prostaglandin receptor subtypes, EP3C and EP4, mediate the prostaglandin E2-induced cAMP production and sensitization of sensory neurons. J. Biol. Chem. 2001 May;276(19):16083-91
Southall MD et al
2001/01/01
PubMed
3 Cheng Y et al. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science 2002 Apr;296(5567):539-41
Cheng Y et al
2002/01/01
PubMed
4 Kuwano K et al. 2-[4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy]-N-(methylsulfonyl)acetamide (NS-304), an orally available and long-acting prostacyclin receptor agonist prodrug. J. Pharmacol. Exp. Ther. 2007 Sep;322(3):1181-8
Kuwano K et al
2007/01/01
PubMed
5 Murata T et al. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 1997 Aug;388(6643):678-82
Murata T et al
1997/01/01
PubMed
6 McLaughlin VV et al. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N. Engl. J. Med. 1998 Jan;338(5):273-7
McLaughlin VV et al
1998/01/01
PubMed
  • No.: 1
  • 文献情報:
    Cui Y et al. Protective effect of prostaglandin I(2) analogs on ischemic delayed neuronal damage in gerbils. Biochem. Biophys. Res. Commun. 1999 Nov;265(2):301-4
    Cui Y et al
    1999/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Southall MD et al. Prostaglandin receptor subtypes, EP3C and EP4, mediate the prostaglandin E2-induced cAMP production and sensitization of sensory neurons. J. Biol. Chem. 2001 May;276(19):16083-91
    Southall MD et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Cheng Y et al. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science 2002 Apr;296(5567):539-41
    Cheng Y et al
    2002/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Kuwano K et al. 2-[4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy]-N-(methylsulfonyl)acetamide (NS-304), an orally available and long-acting prostacyclin receptor agonist prodrug. J. Pharmacol. Exp. Ther. 2007 Sep;322(3):1181-8
    Kuwano K et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Murata T et al. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 1997 Aug;388(6643):678-82
    Murata T et al
    1997/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    McLaughlin VV et al. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N. Engl. J. Med. 1998 Jan;338(5):273-7
    McLaughlin VV et al
    1998/01/01
  • 備考:
  • 参照:
    PubMed